PARAMUS, N.J., May 8, 2019 /PRNewswire/ -- Glenmark Pharmaceuticals, a global innovative pharmaceutical company, today announced positive results from a Phase 3 study of Ryaltris, an investigational ...
MAHWAH, N.J., April 25, 2017 /PRNewswire/ -- Glenmark Pharmaceuticals, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) cleared the company's ...
Glenmark Pharmaceuticals said it has got regulatory approval from China for Ryaltris compound nasal spray, used in the treatment of Allergic Rhinitis (AR) in adults and children. The National Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback